56 related articles for article (PubMed ID: 20711395)
1. Escitalopram induced mania.
Parker S; Nagarsekar BB
Indian J Psychiatry; 2007 Apr; 49(2):121-2. PubMed ID: 20711395
[TBL] [Abstract][Full Text] [Related]
2. Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series.
Yamaguchi Y; Kimoto S; Nagahama T; Kishimoto T
Neuropsychiatr Dis Treat; 2018; 14():2099-2104. PubMed ID: 30147322
[TBL] [Abstract][Full Text] [Related]
3. The importance of long-term tolerability in achieving recovery.
Baldwin DS
Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():31-7. PubMed ID: 24931542
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram: a second-generation SSRI.
Owens MJ; Rosenbaum JF
CNS Spectr; 2002 Apr; 7(4 Suppl 1):34-9. PubMed ID: 15131491
[TBL] [Abstract][Full Text] [Related]
5. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.
Clevenger SS; Malhotra D; Dang J; Vanle B; IsHak WW
Ther Adv Psychopharmacol; 2018 Jan; 8(1):49-58. PubMed ID: 29344343
[TBL] [Abstract][Full Text] [Related]
6. Priorities in treating depression only.
Lam RW
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():25-9. PubMed ID: 24930686
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram-induced severe akathisia leading to suicide attempt.
Pratap A; Akhtar S; Sinha P; Bakhla AK
Ind Psychiatry J; 2019; 28(2):315-317. PubMed ID: 33223729
[TBL] [Abstract][Full Text] [Related]
8. A case report on escitalopram-induced hyperglycaemia in a diabetic patient.
Zuccoli ML; Milano G; Leone S; Fucile C; Brasesco PC; Martelli A; Mattioli F
Int J Psychiatry Med; 2013; 46(2):195-201. PubMed ID: 24552042
[TBL] [Abstract][Full Text] [Related]
9. Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report.
Sato Y; Nakamura K; Yasui-Furukori N
Neuropsychiatr Dis Treat; 2015; 11():2505-7. PubMed ID: 26491328
[TBL] [Abstract][Full Text] [Related]
10. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.
Edinoff AN; Akuly HA; Hanna TA; Ochoa CO; Patti SJ; Ghaffar YA; Kaye AD; Viswanath O; Urits I; Boyer AG; Cornett EM; Kaye AM
Neurol Int; 2021 Aug; 13(3):387-401. PubMed ID: 34449705
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Toxicity From Escitalopram Use
Degiacomo J; Luedtke S
J Pediatr Pharmacol Ther; 2016; 21(6):522-526. PubMed ID: 28018155
[TBL] [Abstract][Full Text] [Related]
12. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Brunoni AR; Moffa AH; Sampaio-Junior B; Borrione L; Moreno ML; Fernandes RA; Veronezi BP; Nogueira BS; Aparicio LVM; Razza LB; Chamorro R; Tort LC; Fraguas R; Lotufo PA; Gattaz WF; Fregni F; Benseñor IM;
N Engl J Med; 2017 Jun; 376(26):2523-2533. PubMed ID: 28657871
[TBL] [Abstract][Full Text] [Related]
13. An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.
Hedges DW; Woon FL
Neuropsychiatr Dis Treat; 2007 Aug; 3(4):455-61. PubMed ID: 19300574
[TBL] [Abstract][Full Text] [Related]
14. Severe hyponatremia associated with escitalopram.
Rawal G; Kumar R; Yadav S
J Family Med Prim Care; 2017; 6(2):453-454. PubMed ID: 29302568
[TBL] [Abstract][Full Text] [Related]
15. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
Owens JM; Knight DL; Nemeroff CB
Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
[TBL] [Abstract][Full Text] [Related]
16. A case of galactorrhea associated with excitalopram.
Shim SH; Lee YJ; Lee EC
Psychiatry Investig; 2009 Sep; 6(3):230-2. PubMed ID: 20046401
[TBL] [Abstract][Full Text] [Related]
17. Current treatment options: relief of symptoms and ultimate recovery.
Kennedy SH
Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():22-6. PubMed ID: 24931540
[TBL] [Abstract][Full Text] [Related]
18. New treatment options for OCD.
Fineberg NA
Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869
[TBL] [Abstract][Full Text] [Related]
19. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
